Pharma Journalist - Page 14 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

AbbVie Invests $380M in North Chicago Manufacturing

FDA Issues Draft Guidance for Individualized Gene Therapies

FDA Approves Calquence-Venetoclax Fixed-Duration Regimen

EU Invests €225M in Next-Generation Flu Vaccines

FDA Approves AbbVie’s Oral CLL Combination Regimen

VivaMed, Syngene Partner to Accelerate AI Drug Validation

Merck, Mayo Clinic Partner on AI Drug Development

Novartis Remibrutinib Shows Phase III Success in CIndU

Johnson & Johnson Reports Promising OrigAMI-4 Trial Results

Boehringer Ingelheim, NIPER Raebareli Sign Research MoU